We describe the preliminary performance characteristics of a novel LiVPO 4 F ʈ LiVPO 4 F lithium-ion cell. The electrochemical evaluation of the LiVPO 4 F phase in metallic lithium half cells indicates that this triclinic fluorophosphate undergoes reversible lithium extraction/insertion reactions at electrode potentials of 1.8 and 4.2 V vs. Li. These insertion properties allow the LiVPO 4 F phase to function successfully as both the positive and negative electrode material in a lithium-ion configuration. We suggest that this type of battery may be particularly useful in commercial applications where considerations such as cost, ease of construction, and safety are at a premium.Phosphate-based insertion phases such as LiFePO 4 and Li 3 V 2 ͑PO 4 ͒ 3 have been identified as electroactive materials for lithium-ion battery applications. 1,2 More recently, the structural and lithium insertion properties of the lithium vanadium fluorophosphate, LiVPO 4 F have been described in detail by this group. 3-7 X-ray powder diffraction studies indicate that the LiVPO 4 F is isostructural with the naturally occurring minerals Tavorite, LiFePO 4 · OH, 8 and Amblygonite, LiAlPO 4 ͑OH,F͒, 9 crystallizing with a triclinic structure ͑space group P1͒. The LiVPO 4 F structure comprises a three-dimensional framework built up from ͓PO 4 ͔ tetrahedra and ͓VO 4 F 2 ͔ octahedra 6,7 with the oxygen atoms shared between the two environments.The reversible lithium extraction/insertion reaction for Li 1−x VPO 4 F, based on the V 3+/4+ redox couple operates at around 4.2 V vs. Li, and as such this fluorophosphate phase may be employed as the positive electrode in conventional graphite-based lithium-ion cells. 6,7 More recent investigations 10 have established an additional lithium insertion reaction ͑composition corresponding to Li 1+x VPO 4 F where x = 0-1͒ at around 1.8 V vs. Li, this time based on the V 2+/3+ redox couple. Based on this information, we report here on the fabrication of symmetrical LiVPO 4 F ʈ LiVPO 4 F lithium-ion cells, in which identical electrode stock is utilized as both the positive and negative electrode material. Separate studies are being carried out by this group to establish the safety characteristics of the LiVPO 4 F material. These will be published in due course. 10
ExperimentalThe LiVPO 4 F used in this study was prepared by a carbothermal reduction ͑CTR͒ method, 11,12 utilizing orthorhombic VPO 4 as reaction intermediate. The precise preparative conditions have been described in detail elsewhere. 5-7 For electrochemical testing, composite electrodes were fabricated using 84 wt % active material, 5 wt % Super P ͑conductive carbon͒, and 11 wt % PVdF-HFP co-polymer ͑Elf Atochem͒ binder. For all electrodes, an aluminum current collector was employed. The electrolyte comprised a 1 M LiPF 6 solution in ethylene carbonate/dimethyl carbonate ͑2:1 by weight͒ while a dried glass fiber filter ͑Whatman, Grade GF/A͒ was used as electrode separator. High-resolution electrochemical measurements were performed using the electr...
The room-temperature structure of SnP2O7 has been investigated using various one- and
two-dimensional (1- and 2D) magic-angle spinning (MAS) NMR experiments. We show that
31P homonuclear through-bond and through-space correlation NMR spectroscopies allow us
to discriminate between the 12 possible space group symmetries of the structure. In
particular, the 31P 2D refocused INADEQUATE experiment allows us to resolve an impressive
number of distinct 31P resonances, showing that the asymmetric unit contains at least 49
different P2O7 groups with two inequivalent P sites. The results suggest that the symmetry
of the SnP2O7 room-temperature structure is monoclinic with space group P21 or Pc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.